CAMPBELL, Calif.--(BUSINESS WIRE)--Kandu™ Health, a tech-enabled healthcare services company that is changing the course of stroke recovery and post-acute care, today announced new data shared at two conferences: the Society of Vascular and Interventional Neurology (SVIN) Annual Meeting in Miami Beach and the Association of Neurovascular Clinicians (ANVC) Annual Conference in Las Vegas.
Preliminary Outcomes from First Graduates of Kandu’s Program
At SVIN, Dr. Nancey Tsai, Medical Director for Kandu Medical Services and Assistant Professor at MUSC College of Medicine, presented a poster titled “Preliminary Outcomes of a Survivor-Centric Digital Platform in Stroke Recovery.” The poster shared results from the first 60 graduates of Kandu’s remote post-acute service. In this analysis, Kandu program graduates experienced all-cause inpatient readmission rates of 4% at 30 days and 10% at 90 days; less than half of historically published unplanned readmission rates in similar populations. In addition, at the end of the 90-day program:
- 97% of patients reported medication adherence
- 92% of patients had completed a neurology follow-up
- 100% of patients had established a relationship with a primary care provider
“For our first evidence presented at an academic conference, our goal was to share preliminary outcomes for the patients cared for to date, and demonstrate the feasibility of delivering remote telemedicine services to post-acute stroke survivors,” said Tudor Jovin, MD, Kandu Health’s Chief Medical Officer. “We are excited about the insights and promise demonstrated in these outcomes and look forward to building on this body of work in the coming year.”
Establishing Feasibility of a Post-Acute Stroke Navigation Platform
The award-winning ANVC 2023 poster by Lauren Sheehan, Sr. Director Clinical Services for Kandu Health, “Complex Needs & Dynamic Solutions – Metrics That Yield Outcomes in a Post-Acute Stroke Navigation Program,” evaluated how post-stroke impairments, Social Determinants of Health, and the presence of a care partner impact survivor engagement and outcomes in a remote post-acute stroke navigation program.
Jennifer Patterson, NP, Director of Neuroscience Operations at CHI Memorial Neuroscience Institute, who led the ANVC poster evaluation, said, “Stroke trials have traditionally categorized any patient who is able to live independently at 90 days (mRS 0-2) as having a ‘good outcome.’ What we see in the Kandu data is that 57% of patients achieving mRS 0-1 and 77% of those achieving mRS 2-3 engaged in 10 or more post-acute Navigator touchpoints over 12 weeks, demonstrating the significant need and opportunity for these services. Kandu’s ability to engage and support patients across a broad spectrum is encouraging.”
“We are excited to see the strong signal from this recent evidence that this work is important, our services are accessible to the communities they serve, and the outcomes we are generating are meaningful,” said Kirsten Carroll, CEO of Kandu Health. “We look forward to continued partnership with our stakeholders to generate additional clinical evidence that demonstrates our value and informs policy and standard of care for stroke survivors.”
About Kandu Health
Kandu Health is a commercial-stage Imperative Care company that provides tech-enabled healthcare services to people recovering from stroke. Kandu Health develops integrated solutions that aid in the stroke recovery process for stroke survivors, their providers, and care partners. Kandu Health provides hospital staff and payers with assurance that their patients are safe and connected to the best resources. Kandu Health began offering its program with its first hospital partners in the greater Los Angeles and South New Jersey areas. Kandu Health is based in Campbell, Calif. https://kanduhealth.com.
